CS
HUMA icon

Credit Suisse’s Humacyte HUMA Stock Holding History

Credit Suisse’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-58,455
Closed -$123K – 3477
2022
Q4 		$123K Buy
58,455
+15,226
+35% +$46.2K ﹤0.01% 3293
2022
Q3 		$140K Buy
43,229
+113
+0.3% +$433 ﹤0.01% 3350
2022
Q2 		$138K Buy
43,116
+5,628
+15% +$31.3K ﹤0.01% 3450
2022
Q1 		$264K Buy
37,488
+2,340
+7% +$13.6K ﹤0.01% 3275
2021
Q4 		$255K Buy
+35,148
New +$348K ﹤0.01% 4185

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
IW
Imprint Wealth Mount Pleasant, South Carolina $21.9M AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse's HUMA Position: Q1 2023 in Review

Credit Suisse sold out of Humacyte (HUMA) in Q1 2023, closing a stake of 58,455 shares — an estimated $123K sold.

Credit Suisse first reported a position in HUMA in Q4 2021 and held it in 5 quarters. The position peaked at $264K in Q1 2022. 69 funds tracked by Wall St. Rank hold HUMA as of Q1 2023.

  • Credit Suisse reported no remaining Humacyte position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 58,455 Humacyte shares in Q1 2023, an estimated $123K.
  • Credit Suisse first reported a position in Humacyte in Q4 2021 and held it in 5 quarters.
  • Credit Suisse's Humacyte position peaked at $264K in Q1 2022.
  • 69 funds tracked by Wall St. Rank held Humacyte as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.